Insider Trading Alert - LNG, UFS, THC, BRE And FCN Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 23, 2013, 95 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $477.16 to $45,000,060.00.

Highlighted Stocks Traded by Insiders:

Cheniere Energy (LNG) - FREE Research Report

Bailey Vicky A who is Director at Cheniere Energy sold 2,150 shares at $42.85 on Dec. 23, 2013. Following this transaction, the Director owned 56,578 shares meaning that the stake was reduced by 3.66% with the 2,150-share transaction.

Abiteboul Jean who is Sr. VP - International at Cheniere Energy sold 60,000 shares at $41.97 on Dec. 23, 2013. Following this transaction, the Sr. VP - International owned 854,639 shares meaning that the stake was reduced by 6.56% with the 60,000-share transaction.

Gentle Meg who is Sr. VP - Marketing at Cheniere Energy sold 240,000 shares at $41.17 on Dec. 23, 2013. Following this transaction, the Sr. VP - Marketing owned 1.4 million shares meaning that the stake was reduced by 14.44% with the 240,000-share transaction.

The shares most recently traded at $43.68, up $2.51, or 5.75% since the insider transaction. Historical insider transactions for Cheniere Energy go as follows:

  • 4-Week # shares sold: 66,500
  • 12-Week # shares sold: 214,500
  • 24-Week # shares sold: 459,000

The average volume for Cheniere Energy has been 3.6 million shares per day over the past 30 days. Cheniere Energy has a market cap of $10.3 billion and is part of the basic materials sector and energy industry. Shares are up 129.18% year-to-date as of the close of trading on Monday.

Cheniere Energy, Inc., an energy company, engages in the liquefied natural gas (LNG) related business. It operates through two segments, LNG Terminal Business, and LNG and Natural Gas Marketing Business. Currently there are 4 analysts that rate Cheniere Energy a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LNG - FREE

TheStreet Quant Ratings rates Cheniere Energy as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and generally higher debt management risk. Get the full Cheniere Energy Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Domtar (UFS) - FREE Research Report

Gignac Louis P who is Director at Domtar sold 2,000 shares at $91.77 on Dec. 23, 2013. Following this transaction, the Director owned 0 shares meaning that the stake was reduced by 100% with the 2,000-share transaction.

The shares most recently traded at $94.52, up $2.75, or 2.91% since the insider transaction. Historical insider transactions for Domtar go as follows:

  • 4-Week # shares sold: 1,308
  • 12-Week # shares sold: 9,693
  • 24-Week # shares sold: 12,596

The average volume for Domtar has been 341,300 shares per day over the past 30 days. Domtar has a market cap of $2.9 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 9.69% year-to-date as of the close of trading on Monday.

Domtar Corporation designs, manufactures, markets, and distributes communications papers, specialty and packaging papers, and adult incontinence products worldwide. It operates in three segments: Pulp and Paper, Distribution, and Personal Care. The stock currently has a dividend yield of 2.4%. The company has a P/E ratio of 68.9. Currently there are 9 analysts that rate Domtar a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UFS - FREE

TheStreet Quant Ratings rates Domtar as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full Domtar Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Tenet Healthcare (THC) - FREE Research Report

Glenview Capital Management, Llc who is 10% Owner at Tenet Healthcare bought 644,582 shares at $39.95 on Dec. 23, 2013. Following this transaction, the 10% Owner owned 13.6 million shares meaning that the stake was reduced by 4.99% with the 644,582-share transaction.

The shares most recently traded at $40.96, up $1.01, or 2.47% since the insider transaction. Historical insider transactions for Tenet Healthcare go as follows:

  • 4-Week # shares bought: 6,250
  • 12-Week # shares bought: 25,000
  • 12-Week # shares sold: 16,582
  • 24-Week # shares bought: 25,000
  • 24-Week # shares sold: 24,873

The average volume for Tenet Healthcare has been 1.9 million shares per day over the past 30 days. Tenet Healthcare has a market cap of $4.0 billion and is part of the health care sector and health services industry. Shares are up 24.15% year-to-date as of the close of trading on Monday.

Tenet Healthcare Corporation, an investor-owned health care services company, owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, urgent care centers, and related health care facilities in the United States. Currently there are 8 analysts that rate Tenet Healthcare a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on THC - FREE

TheStreet Quant Ratings rates Tenet Healthcare as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share and revenue growth. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity. Get the full Tenet Healthcare Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

BRE Properties (BRE) - FREE Research Report

Fanwick Kerry who is EVP, General Counsel at BRE Properties sold 1,000 shares at $54.03 on Dec. 23, 2013. Following this transaction, the EVP, General Counsel owned 57,240 shares meaning that the stake was reduced by 1.72% with the 1,000-share transaction.

The shares most recently traded at $55.15, up $1.12, or 2.03% since the insider transaction. Historical insider transactions for BRE Properties go as follows:

  • 4-Week # shares sold: 1,000
  • 12-Week # shares sold: 2,500
  • 24-Week # shares sold: 8,500

The average volume for BRE Properties has been 965,500 shares per day over the past 30 days. BRE Properties has a market cap of $4.2 billion and is part of the financial sector and real estate industry. Shares are up 8.38% year-to-date as of the close of trading on Monday.

BRE Properties Inc. is an independent real estate investment trust. The firm invests in the real estate markets of the United States. It focuses on the development, acquisition, and management of multifamily apartment communities. BRE Properties Inc. The stock currently has a dividend yield of 2.92%. The company has a P/E ratio of 25.0. Currently there are no analysts that rate BRE Properties a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BRE - FREE

TheStreet Quant Ratings rates BRE Properties as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, increase in stock price during the past year and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full BRE Properties Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

FTI Consulting (FCN) - FREE Research Report

Bacon Brenda J who is Director at FTI Consulting sold 11,000 shares at $41.39 on Dec. 23, 2013. Following this transaction, the Director owned 26,785 shares meaning that the stake was reduced by 29.11% with the 11,000-share transaction.

The shares most recently traded at $41.31, down $0.08, or 0.18% since the insider transaction. Historical insider transactions for FTI Consulting go as follows:

  • 4-Week # shares sold: 318,646
  • 12-Week # shares sold: 318,646
  • 24-Week # shares sold: 318,646

The average volume for FTI Consulting has been 330,600 shares per day over the past 30 days. FTI Consulting has a market cap of $1.7 billion and is part of the services sector and diversified services industry. Shares are up 25.18% year-to-date as of the close of trading on Monday.

FTI Consulting, Inc., together with its subsidiaries, operates as a business advisory firm enabling organizations to protect enterprise values in complex economic, legal, and regulatory, environments worldwide. Currently there are 2 analysts that rate FTI Consulting a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FCN - FREE

TheStreet Quant Ratings rates FTI Consulting as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full FTI Consulting Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Amazon's Big Weakness in the Supreme Court Sales Tax Ruling

Amazon's Big Weakness in the Supreme Court Sales Tax Ruling

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Tesla's Automotive Gross Margins May Be Overstated, Analysts Suggest

Tesla's Automotive Gross Margins May Be Overstated, Analysts Suggest

Dow Rises for First Time in 9 Days, Oil Soars as OPEC Agrees to Boost Output

Dow Rises for First Time in 9 Days, Oil Soars as OPEC Agrees to Boost Output

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices